TARGET-NASH encompasses a unique retrospective/prospective longitudinal cohort design that will define the natural history of NASH, establish important patient level baseline disease characteristics against which to judge subsequent interventions, and evaluate the safety and effectiveness of novel therapies as they are utilized in the post-marketing environment.
Child to Adult
University of Colorado Hospital
Whitney Jackson, MD
Protocol Number: 17-0051
More information available at ClinicalTrials.gov: NCT02815891
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers